Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 12, 2017, Pages 2491-2494

  Ip, Margaret ^a   Lai, Christopher K ^b   Fung, Kitty S C ^c   Wong, K Tak ^a   Zhu, Chendi ^a   Van de Velde, Sebastien ^d   Tsang, Dominic N ^b   Hawkey, Peter ^e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d Eumedica SA   (Belgium)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TEMOCILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HONG KONG; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PUBLIC HOSPITAL; URINE; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; COLISTIN; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FOSFOMYCIN; HONG KONG; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PUBLIC HEALTH SURVEILLANCE;

EID: 85028329189     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-3091-8     Document Type: Article

References (15)

1. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M B-lactamases: temporal and geographical shifts in genotype. J Antimcirob Chemother 2017;72(8):2145–2155. https://doi.org/10.1093/jac/dkx146
2. Chang YT, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H et al (2017) Epidemiology and trends in the antibiotic susceptibilities of gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010–2013. Int J Antimicrob Agents 49:734–739. https://doi.org/10.1016/j.ijantimicag.2017.01.030
3. You JHS, Mok SSM, Chang CCM, Lee N, Ip M (2009) Bacteraemia with extended-spectrum β-lactamases-producing Escherichia coli in Hong Kong. Int J Antimicrob Agents 34:611–612. https://doi.org/10.1016/j.ijantimicag.2009.07.015
4. Pau CKY, Ma FFT, Ip M, You JHS (2015) Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong. Infect Dis (Auckl) 47:283–288. https://doi.org/10.3109/00365548.2014.985710
5. Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B et al (2011) Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 66:2628–2631. https://doi.org/10.1093/jac/dkr317
6. Habayeb H, Sajin B, Patel K, Grundy C, Al-Dujaili A, Van de Velde S (2015) Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit. Eur J Clin Microbiol Infect Dis 34:1693–1699. https://doi.org/10.1007/s10096-015-2406-x
7. El Sakka N, Gould IM (2016) Role of old antimicrobial agents in the management of urinary tract infection. Expert Rev Clin Pharmacol 9:1047–1056. https://doi.org/10.1080/17512433.2016.1189325
8. Andrews JM, Jevons G, Walker R, Ashby J, Fraise AP (2007) Temocillin susceptibility by BSAC methodology. J Antimicrob Chemother 60:185–187. https://doi.org/10.1093/jac/dkm179
9. CLSI (2015) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th edn. Clinical and Laboratory Standards Institute, Wayne, PA
10. CLSI (2015) Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA
11. Andrews JM. BSAC Susceptibility Testing Guide. Chapter 2. Determination of minimum inhibitory concentrations. http://www.bsac.org.uk/stewardship-surveillance/susceptibility/susceptibility-testing-guide. Accessed 5 August 2017
12. Reynolds R, Shackcloth J, Felmingham D, MacGowan A (2003) Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC respiratory resistance surveillance programme. J Antimicrob Chemother 52:925–930
13. Seo MR, Kim SJ, Kim Y, Kim J, Choi TY, Kang JO et al (2014) Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. J Korean Med Sci 29:1178–1181. https://doi.org/10.3346/jkms.2014.29.8.1178
14. Kim B, Kim J, Seo MR, Wie SH, Cho YK, Lim SK et al (2013) Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. Infection 41:603–612. https://doi.org/10.1007/s15010-013-0441-z
15. Chen YT, Murad KA, Ng LSY, Seah JTH, Park JJ, Tan TY et al (2016) In vitro efficacy of six alternative antibiotics against multidrug resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections. Ann Acad Med Singapore 45:245–250